Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Int J Mol Sci ; 22(9)2021 Apr 29.
Article in English | MEDLINE | ID: mdl-33947115

ABSTRACT

Cortisol, a stress hormone, plays key roles in mediating stress and anti-inflammatory responses. As abnormal cortisol levels can induce various adverse effects, screening cortisol and cortisol analogues is important for monitoring stress levels and for identifying drug candidates. A novel cell-based sensing system was adopted for rapid screening of cortisol and its functional analogues under complex cellular regulation. We used glucocorticoid receptor (GR) fused to a split intein which reconstituted with the counterpart to trigger conditional protein splicing (CPS) in the presence of targets. CPS generates functional signal peptides which promptly translocate the fluorescent cargo. The sensor cells exhibited exceptional performance in discriminating between the functional and structural analogues of cortisol with improved sensitivity. Essential oil extracts with stress relief activity were screened using the sensor cells to identify GR effectors. The sensor cells responded to peppermint oil, and L-limonene and L-menthol were identified as potential GR effectors from the major components of peppermint oil. Further analysis indicated L-limonene as a selective GR agonist (SEGRA) which is a potential anti-inflammatory agent as it attenuates proinflammatory responses without causing notable adverse effects of GR agonists.


Subject(s)
Biosensing Techniques , Drug Evaluation, Preclinical/methods , Fluorescence Polarization/methods , Hydrocortisone/analysis , Oils, Volatile/pharmacology , Receptors, Glucocorticoid/agonists , Atrophy , Cyproterone Acetate/pharmacology , Dexamethasone/pharmacology , Estradiol/pharmacology , Fluorometry , HeLa Cells , Humans , Inteins , Limonene/pharmacology , Luminescent Proteins/analysis , Mentha piperita , Menthol/pharmacology , Mifepristone/pharmacology , Molecular Structure , Muscle, Skeletal/pathology , Myoblasts/drug effects , Plant Oils/pharmacology , Protein Splicing , Protein Transport , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Red Fluorescent Protein
2.
Eur J Pharmacol ; 890: 173669, 2021 Jan 05.
Article in English | MEDLINE | ID: mdl-33098832

ABSTRACT

Glioma is the most common primary intracranial tumor, in which glioblastoma (GBM) is the most malignant and lethal. However, the current chemotherapy drugs are still unsatisfactory for GBM therapy. As the natural products mainly extracted from Eucalyptus species, phloroglucinol-terpene adducts have the potential to be anti-cancer lead compounds that attracted increasing attention. In order to discover the new lead compounds with the anti-GBM ability, we isolated Eucalyptal A with a phloroglucinol-terpene skeleton from the fruit of E. globulus and investigated its anti-GBM activity in vitro and in vivo. Functionally, we verified that Eucalyptal A could inhibit the proliferation, growth and invasiveness of GBM cells in vitro. Moreover, Eucalyptal A had the same anti-GBM activity in tumor-bearing mice as in vitro and prolonged the overall survival time by maintaining mice body weight. Further mechanism research revealed that Eucalyptal A downregulated SRSF1 expression and rectified SRSF1-guided abnormal alternative splicing of MYO1B mRNA, which led to anti-GBM activity through the PDK1/AKT/c-Myc and PAK/Cofilin axes. Taken together, we identified Eucalyptal A as an important anti-GBM lead compound, which represents a novel direction for glioma therapy.


Subject(s)
Brain Neoplasms/metabolism , Carcinogenesis/drug effects , Eucalyptol/therapeutic use , Glioma/metabolism , Myosin Type I/metabolism , Protein Splicing/drug effects , Serine-Arginine Splicing Factors/biosynthesis , Animals , Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/therapeutic use , Brain Neoplasms/genetics , Brain Neoplasms/prevention & control , Carcinogenesis/metabolism , Carcinogenesis/pathology , Cell Line, Tumor , Drugs, Chinese Herbal/isolation & purification , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Eucalyptol/isolation & purification , Eucalyptol/pharmacology , Gene Expression Regulation, Neoplastic , Glioma/genetics , Glioma/prevention & control , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , Myosin Type I/genetics , Protein Splicing/physiology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Serine-Arginine Splicing Factors/antagonists & inhibitors , Serine-Arginine Splicing Factors/genetics , Xenograft Model Antitumor Assays/methods
3.
Chembiochem ; 20(15): 1933-1938, 2019 08 01.
Article in English | MEDLINE | ID: mdl-30963690

ABSTRACT

Protein-splicing domains are frequently used engineering tools that find application in the in vivo and in vitro ligation of protein domains. Directed evolution is among the most promising technologies used to advance this technology. However, the available screening systems for protein-splicing activity are associated with bottlenecks such as the selection of pseudo-positive clones arising from off-pathway reaction products or fragment complementation. Herein, we report a stringent screening method for protein-splicing activity in cis and trans, that exclusively selects productively splicing domains. By fusing splicing domains to an intrinsically disordered region of the antidote from the Escherichia coli CcdA/CcdB type II toxin/antitoxin system, we linked protein splicing to cell survival. The screen allows selecting novel cis- and trans-splicing inteins catalyzing productive highly efficient protein splicing, for example, from directed-evolution approaches or the natural intein sequence space.


Subject(s)
Antitoxins/pharmacology , Bacterial Proteins/antagonists & inhibitors , Protein Splicing/drug effects , Antitoxins/chemistry , Bacterial Proteins/metabolism , Cell Survival/drug effects , Drug Evaluation, Preclinical , Escherichia coli/chemistry , Escherichia coli/drug effects , Models, Molecular
4.
Methods Mol Biol ; 847: 123-35, 2012.
Article in English | MEDLINE | ID: mdl-22351004

ABSTRACT

The establishment of traits that result from the concerted expression of complementing transgene fragments is a feasible tool for trait control or gene flow control in plants. This chapter describes the methodology for producing herbicide-resistant and pollen-sterile wheat plants by the intein-mediated assembly of inactive precursor protein fragments (protein trans-splicing). We suggest the design of intein-containing vectors for split-transgene expression. We describe transient plant assays that can be used to analyse the functionality of the system and describe the transformation of wheat plants using a split selection marker.We hope that this chapter will be a helpful guideline for researchers who are interested in applying similar split-gene approaches in wheat or other monocotyledonous crops.


Subject(s)
Acetolactate Synthase/genetics , Herbicide Resistance/genetics , Transgenes , Triticum/genetics , Bacterial Proteins , Genetic Vectors , Herbicides/pharmacology , Inteins/genetics , Plants, Genetically Modified/genetics , Pollen/genetics , Pollen/physiology , Protein Splicing , Ribonucleases/biosynthesis , Ribonucleases/genetics , Synechocystis/genetics , Nicotiana/genetics , Trans-Splicing
5.
Neuron ; 73(2): 279-91, 2012 Jan 26.
Article in English | MEDLINE | ID: mdl-22284183

ABSTRACT

Regulation of corticotropin-releasing hormone (CRH) activity is critical for the animal's adaptation to stressful challenges, and its dysregulation is associated with psychiatric disorders in humans. However, the molecular mechanism underlying this transcriptional response to stress is not well understood. Using various stress paradigms in mouse and zebrafish, we show that the hypothalamic transcription factor Orthopedia modulates the expression of CRH as well as the splicing factor Ataxin 2-Binding Protein-1 (A2BP1/Rbfox-1). We further show that the G protein coupled receptor PAC1, which is a known A2BP1/Rbfox-1 splicing target and an important mediator of CRH activity, is alternatively spliced in response to a stressful challenge. The generation of PAC1-hop messenger RNA isoform by alternative splicing is required for termination of CRH transcription, normal activation of the hypothalamic-pituitary-adrenal axis and adaptive anxiety-like behavior. Our study identifies an evolutionarily conserved biochemical pathway that modulates the neuronal adaptation to stress through transcriptional activation and alternative splicing.


Subject(s)
Adaptation, Physiological/physiology , Neurons/metabolism , Stress, Physiological/physiology , Transcription Factors/metabolism , Zebrafish Proteins/metabolism , Animals , Animals, Genetically Modified , Anxiety/metabolism , Behavior, Animal/physiology , Dual Specificity Phosphatase 2/metabolism , Hypothalamus/metabolism , Protein Splicing , Zebrafish
6.
Cell Calcium ; 51(1): 57-64, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22133610

ABSTRACT

While genetically encoded Ca(2+) indicators (GECIs) allow Ca(2+) imaging in model organisms, the gene expression is often under the control of a single promoter that may drive expression beyond, the cell types of interest. To enable more cell-type specific targeting, GECIs can be brought under the, control of the intersecting expression from two promoters. Here, we present the splitting and, reassembly of two representative GECIs (TN-XL and GCaMP2) mediated by the split intein from Nostoc, punctiforme (NpuDnaE). While the split TN-XL biosensor offered ratiometric Ca(2+) imaging, it had a, diminished Ca(2+) response relative to the native TN-XL biosensor. In contrast, the split GCaMP2, biosensor retained similar Ca(2+) response to the native GCaMP2. The split GCaMP2 biosensor was, further targeted to the pharyngeal muscles of Caenorhabditis elegans where Ca(2+) signals from feeding C. elegans, were imaged. Thus, we envision that increased cell-type targetability of GECIs is feasible with two, complementary promoters.


Subject(s)
Calcium/metabolism , Inteins , Molecular Probes/metabolism , Protein Splicing , Animals , Caenorhabditis elegans/metabolism , Calcium Signaling , Cell Line , DNA Polymerase III/metabolism , Humans , Indicators and Reagents , Mammals , Nostoc/metabolism , Pharynx/metabolism
7.
FEBS J ; 278(18): 3431-46, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21787376

ABSTRACT

A split-intein consists of two complementary fragments (N-intein and C-intein) that can associate to carry out protein trans-splicing. The Ssp GyrB S11 split-intein is an engineered unconventional split-intein consisting of a 150-amino-acid N-intein and an extremely small six-amino-acid C-intein, which comprises the conserved intein motif G. Here, we show that fusion proteins containing the 150-amino-acid N-intein could be triggered to undergo controllable N-cleavage in vitro when the six-amino-acid C-intein or a derivative thereof was added as a synthetic peptide in trans. More importantly, we discovered, unexpectedly, that the 150-amino-acid N-intein could be induced by strong nucleophiles to undergo N-cleavage in vitro, and in Escherichia coli cells, in the absence of the motif G-containing six-amino-acid C-intein. This finding indicated that the first step of the protein splicing mechanism (acyl shift) could occur in the absence of the entire motif G. Extensive kinetic analyses revealed that both the motif G residues and the Ser+1 residue positively influenced N-cleavage rate constants and yields. The 150-amino-acid N-intein could also tolerate various unrelated sequences appended to its C-terminus without disruption of the N-cleavage function, suggesting that the catalytic pocket of the intein has considerable structural flexibility. Our findings reveal interesting insights into intein structure-function relationships, and demonstrate a new and potentially more useful method of controllable, intein-mediated N-cleavage for protein engineering applications.


Subject(s)
Bacterial Proteins/chemistry , DNA Gyrase/chemistry , Enzyme Precursors/chemistry , Inteins , Peptide Fragments/chemistry , Protein Interaction Domains and Motifs , Protein Splicing , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Bacterial Proteins/metabolism , Catalysis , DNA Gyrase/genetics , DNA Gyrase/isolation & purification , DNA Gyrase/metabolism , Dithiothreitol/pharmacology , Enzyme Precursors/genetics , Enzyme Precursors/isolation & purification , Enzyme Precursors/metabolism , Enzyme Stability , Hydroxylamine/pharmacology , Kinetics , Mesna/pharmacology , Mutant Proteins/chemistry , Mutant Proteins/genetics , Mutant Proteins/isolation & purification , Mutant Proteins/metabolism , Oligopeptides/metabolism , Peptide Fragments/genetics , Peptide Fragments/isolation & purification , Peptide Fragments/metabolism , Protein Engineering/methods , Protein Splicing/drug effects , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Reducing Agents/pharmacology , Synechocystis/enzymology , Zinc/pharmacology
8.
J Biol Chem ; 286(2): 1277-82, 2011 Jan 14.
Article in English | MEDLINE | ID: mdl-21059649

ABSTRACT

Mycobacterium tuberculosis harbors three protein splicing elements, called inteins, in critical genes and their protein products. Post-translational removal of the inteins occurs autocatalytically and is required for function of the respective M. tuberculosis proteins. Inteins are therefore potential targets for antimycobacterial agents. In this work, we report that the splicing activity of the intein present in the RecA recombinase of M. tuberculosis is potently inhibited by the anticancer drug cisplatin (cis-diamminedichloro-platinum(II)). This previously unrecognized activity of cisplatin was established using both an in vitro intein splicing assay, which yielded an IC(50) of ∼2 µM, and a genetic reporter for intein splicing in Escherichia coli. Testing of related platinum(II) complexes indicated that the inhibition activity is highly structure-dependent, with cisplatin exhibiting the best inhibitory effect. Finally, we report that cisplatin is toxic toward M. tuberculosis with a minimum inhibitory concentration of ∼40 µM, and in genetic experiments conducted with the related Mycobacterium bovis bacillus Calmette-Guérrin (BCG) strain, we show that cisplatin toxicity can be mitigated by intein overexpression. We propose that cisplatin inhibits intein activity by modifying at least one conserved cysteine residue that is required for splicing. Together these results identify a novel active site inhibitor of inteins and validate inteins as viable targets for small molecule inhibition in mycobacteria.


Subject(s)
Cisplatin/pharmacology , Inteins/drug effects , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/genetics , Protein Splicing/drug effects , Antineoplastic Agents/pharmacology , Drug Design , Escherichia coli/genetics , Gene Expression Regulation, Bacterial/drug effects , Genes, Reporter , Green Fluorescent Proteins/genetics , Microbial Sensitivity Tests , Mycobacterium bovis/drug effects , Mycobacterium bovis/genetics , Mycobacterium bovis/growth & development , Mycobacterium tuberculosis/growth & development , Platinum Compounds/pharmacology , Rec A Recombinases/genetics , Rec A Recombinases/metabolism
9.
J Pept Sci ; 16(10): 575-81, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20862725

ABSTRACT

Split inteins link their fused peptide or protein sequences with a peptide bond in an autocatalytic reaction called protein trans-splicing. This reaction is becoming increasingly important for a variety of applications in protein semisynthesis, polypeptide circularisation, construction of biosensors, or segmental isotopic labelling of proteins. However, split inteins exhibit greatly varying solubility, efficiency and tolerance towards the nature of the fused sequences as well as reaction conditions. We envisioned that phage display as an in vitro selection technique would provide a powerful tool for the directed evolution of split inteins with improved properties. As a first step towards this goal, we show that presentation of active split inteins on an M13 bacteriophage is feasible. Two different C-terminal intein fragments of the Ssp DnaB intein, artificially split at amino acid positions 104 and 11, were encoded in a phagemid vector in fusion to a truncated gpIII protein. For efficient production of hybrid phages, the presence of a soluble domain tag at their N-termini was necessary. Immunoblot analysis revealed that the hybrid phages supported protein trans-splicing with a protein or a synthetic peptide, respectively, containing the complementary intein fragment. Incorporation of biotin or desthiobiotin by this reaction provides a straightforward strategy for future enrichment of desired mutants from randomised libraries of the C-terminal intein fragments on streptavidin beads. Protein semisynthesis on a phage could also be exploited for the selection of chemically modified proteins with unique properties.


Subject(s)
Bacteriophage M13/genetics , Directed Molecular Evolution , Inteins/genetics , Protein Splicing , Trans-Splicing , Peptide Library , Peptides/genetics , Peptides/metabolism
10.
Chembiochem ; 9(14): 2317-25, 2008 Sep 22.
Article in English | MEDLINE | ID: mdl-18756552

ABSTRACT

The selective modification of proteins with a synthetic probe is of central interest for many aspects of protein chemistry. We have recently reported a new approach in which a short cysteine-containing tag (CysTag) fused to one part of a split intein is first modified with a sulfhydryl-reactive probe. In a second step, protein trans-splicing is used to link the labelled CysTag to a target protein that has been expressed in fusion with the complementary split intein fragment. Here, we present the generation and biochemical characterisation of the artificially split Mycobacterium xenopi GyrA intein. We show that this split intein is active without a renaturation step and that it provides a significant improvement for the CysTag protein-labelling approach in terms of product yields and target protein tolerance. Two proteins with multiple cysteine residues, human growth hormone and a multidomain nonribosomal peptide synthetase, were site-specifically modified with high yields. Our approach combines the benefits of the plethora of commercially available cysteine-reactive probes with a straightforward route for their site-specific incorporation even into complex and cysteine-rich proteins.


Subject(s)
Cysteine/metabolism , DNA Gyrase/chemistry , DNA Gyrase/metabolism , Inteins , Mycobacterium xenopi/enzymology , Protein Splicing , Proteins/chemistry , Amino Acid Sequence , Human Growth Hormone/chemistry , Human Growth Hormone/metabolism , Humans , Molecular Sequence Data , Molecular Weight , Peptide Synthases/chemistry , Peptide Synthases/metabolism , Proteins/metabolism , Solubility , Staining and Labeling , Substrate Specificity
11.
J Exp Bot ; 58(5): 1133-41, 2007.
Article in English | MEDLINE | ID: mdl-17237158

ABSTRACT

Modern garlic (Allium sativum L.) cultivars are sterile and propagated only vegetatively. The recent discovery of fertile genotypes in Central Asia and the restoration of flowering and fertility by environmental manipulations open the way for in-depth florogenetic, genetic, and molecular research in garlic. In the present work, two bolting garlic accessions were employed: #3026, developing normal flowers and seeds, and #2509, in which flowers abort at the early stages of development. Morphological studies showed transition of the apical meristems from the vegetative to the reproductive stage and inflorescence initiation in both genotypes. Low temperatures promote transition of the apex and stem elongation, but have no effect on the phenotypic expression of the inflorescence development. The initial stages of reproductive development in non-flowering #2509 plants were followed by abortion of floral primordia at the differentiation stage. A search for genes involved in the control of flowering in garlic resulted in identification of the garlic LEAFY/FLO homologue, gaLFY. Further comparative analyses of gene expression revealed two gaLFY transcripts, differing in 64 nucleotides, with clear splicing borders. The short variant transcript was identified in both genotypes throughout all development stages, whereas the long variant appears in the flowering genotype #3026 only during reproductive development. The phenotypic differences in garlic, with regard to flowering, may be associated with the efficacy of the splicing process.


Subject(s)
Garlic/metabolism , Gene Expression Regulation, Plant/physiology , Plant Proteins/metabolism , Protein Splicing/physiology , Amino Acid Sequence , Flowers/metabolism , Flowers/ultrastructure , Garlic/ultrastructure , Molecular Sequence Data , Plant Proteins/chemistry , Plant Proteins/genetics , Reproduction/physiology
12.
Am J Kidney Dis ; 48(5): e73-9, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17059986

ABSTRACT

We report a case of Gitelman syndrome (GS) in a dizygotic twin who presented at 12 years of age with growth delay, metabolic alkalosis, hypomagnesemia and hypokalemia with inappropriate kaliuresis, and idiopathic intracranial hypertension with bilateral papilledema (pseudotumor cerebri). The patient, her twin sister, and her mother also presented with cerebral cavernous malformations. Based on the early onset and normocalciuria, Bartter syndrome was diagnosed first. However, mutation analysis showed that the proband is a compound heterozygote for 2 mutations in SLC12A3: a substitution of serine by leucine at amino acid position 555 (p.Ser555Leu) and a novel guanine to cytosine transition at the 5' splice site of intron 22 (c.2633+1G>C), providing the molecular diagnosis of GS. These mutations were not detected in 200 normal chromosomes and cosegregated within the family. Analysis of complementary DNA showed that the heterozygous nucleotide change c.2633+1G>C caused the appearance of 2 RNA molecules, 1 normal transcript and 1 skipping the entire exon 22 (r.2521_2634del). Supplementation with potassium and magnesium improved clinical symptoms and resulted in catch-up growth, but vision remained impaired. Three similar associations of Bartter syndrome/GS with pseudotumor cerebri were found in the literature, suggesting that electrolyte abnormalities and secondary aldosteronism may have a role in idiopathic intracranial hypertension. This study provides further evidence for the phenotypical heterogeneity of GS and its association with severe manifestations in children. It also shows the independent segregation of familial cavernomatosis and GS.


Subject(s)
Diseases in Twins/genetics , Gitelman Syndrome/genetics , Protein Splicing/genetics , Pseudotumor Cerebri/genetics , Receptors, Drug/genetics , Symporters/genetics , Alkalosis/genetics , Bartter Syndrome/genetics , Child , DNA Mutational Analysis , Diuretics , Female , Growth Disorders/genetics , Humans , Hypokalemia/genetics , Magnesium Deficiency/genetics , Magnetic Resonance Imaging , Mutation , Pedigree , Pseudotumor Cerebri/complications , Pseudotumor Cerebri/diagnosis , Solute Carrier Family 12, Member 3 , Syndrome
13.
J Cell Biol ; 172(4): 565-75, 2006 Feb 13.
Article in English | MEDLINE | ID: mdl-16461360

ABSTRACT

Upon the accumulation of unfolded proteins in the mammalian endoplasmic reticulum (ER), X-box binding protein 1 (XBP1) premessenger RNA (premRNA) is converted to mature mRNA by unconventional splicing that is mediated by the endonuclease inositol-requiring enzyme 1. The transcription factor protein (p) XBP1 spliced (S), which is translated from mature XBP1 mRNA, contains the nuclear localization signal and the transcriptional activation domain and activates the transcription of target genes, including those encoding ER chaperones in the nucleus. We show that pXBP1 unspliced (U) encoded in XBP1 pre-mRNA was constitutively expressed and markedly accumulated at the recovery phase of ER stress. pXBP1(U) contained the nuclear exclusion signal instead of the transcriptional activation domain and shuttled between the nucleus and the cytoplasm. Interestingly, pXBP1(U) formed a complex with pXBP1(S), and the pXBP1(U)-pXBP1(S) complex was sequestered from the nucleus. Moreover, the complex was rapidly degraded by proteasomes because of the degradation motif contained in pXBP1(U). Thus, pXBP1(U) is a negative feedback regulator of pXBP1(S), which shuts off the transcription of target genes during the recovery phase of ER stress.


Subject(s)
DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Endoplasmic Reticulum/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Protein Folding , Protein Splicing/physiology , RNA Precursors/metabolism , Animals , Cell Nucleus/metabolism , Cells, Cultured , Cycloheximide/pharmacology , Cytoplasm/metabolism , Dithiothreitol/pharmacology , Endoplasmic Reticulum/drug effects , Feedback, Physiological/drug effects , Gene Expression Regulation/drug effects , HeLa Cells , Humans , Protein Transport/drug effects , RNA Precursors/genetics , RNA, Messenger/biosynthesis , Regulatory Factor X Transcription Factors , Transcription Factors , X-Box Binding Protein 1
14.
Anal Chem ; 75(10): 2456-62, 2003 May 15.
Article in English | MEDLINE | ID: mdl-12918990

ABSTRACT

This paper describes an in vitro fluorometric assay system for protein splicing based on the RecA intein of Mycobacterium tuberculosis and a modified green fluorescent protein (GFP). The assay takes advantage of the fact that polypeptides inserted adjacent to residue 129 of GFP cause the protein to form inclusion bodies when expressed in Escherichia coli and to be incapable of fluorophore formation. However, when the inserted polypeptide is an intein, the renatured fusion protein can undergo protein splicing and chromophore formation. Comparison of chromophore formation by renatured GFP-intein fusion and renatured GFP showed that under optimal conditions (pH 6.5 and 20 degrees C) protein splicing is significantly slower than GFP chromophore formation. Taking advantage of the reversible inhibition of protein splicing by zinc ion, a fluorometric protein splicing assay was developed in which the denatured fusion protein of GFP and the RecA intein was purified on a metal ion affinity column and renatured in the presence of 2 mM ZnCl2. When diluted into appropriate buffers, protein splicing could be initiated by the addition of a molar excess of EDTA and followed fluorometrically. This assay should be valuable as a high-throughput screening system for protein splicing inhibitors as potential antimycobacterial agents and as tools for studying the mechanism of protein splicing.


Subject(s)
Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Fluorometry/methods , Luminescent Proteins/chemistry , Protein Splicing , Rec A Recombinases/chemistry , Drug Evaluation, Preclinical/methods , Green Fluorescent Proteins , Mycobacterium tuberculosis , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
15.
Regul Pept ; 111(1-3): 21-9, 2003 Mar 28.
Article in English | MEDLINE | ID: mdl-12609745

ABSTRACT

Recently, an orphan G protein coupled receptor (GPCR) termed NPGPR was described. A shorter variant of this receptor lacking exon 1 was shown to have subnanomolar affinity for neuropeptide FF (NPFF), a pain modulatory peptide, and therefore was named NPFF(2) receptor. Here, we characterize the full-length cloned NPGPR and identify a novel short form lacking exon 2 with a differential pattern of mRNA abundance in several tissues and organs. The NPGPR is most similar to the recently cloned neuropeptide FF (NPFF) receptor which lacks exon 1, but also shows high homology to the orexin and neuropeptide Y (NPY) receptor families, two neuropeptides involved in food intake regulation. Therefore, we used binding studies to examine the interaction of NPFF, orexin and NPY with the NPGPR. [125I] NPFF was displaced by NPFF with an IC(50) of 14.7 +/- 8.8 nM, whereas [125I] Orexin B was displaced by Orexin B with an IC(50) of 415 +/- 195 nM. We conclude that orexins interact with the NPGPR and that the affinity of NPFF for NPGPR is approximately 100-fold lower than for the NPFF2 receptor. We postulate that NPGPR is a splice variant of the family of NPFF receptors and displays a binding profile different from the other members of the NPFF receptor family due to the presence of exon 1. In order to evaluate whether NPGPR levels are affected by the feeding status, we examined the mRNA level using real-time PCR in two feeding models, i.e. before and after diet-induced body weight increase as well as after chronic food restriction in rats. However, hypothalamic NPGPR mRNA was unchanged in both models. Therefore, our evidence does not support the hypothesis that NPGPR is involved in feeding regulation.


Subject(s)
Hypothalamus/metabolism , Intracellular Signaling Peptides and Proteins , Pregnancy Proteins/genetics , RNA, Messenger/genetics , Receptors, G-Protein-Coupled/genetics , Receptors, Neuropeptide/genetics , Amino Acid Sequence , Animals , CHO Cells , Carrier Proteins/metabolism , Cloning, Molecular , Cricetinae , Exons , Humans , Molecular Sequence Data , Neuropeptides/metabolism , Orexin Receptors , Orexins , Pregnancy Proteins/metabolism , Protein Isoforms/genetics , Protein Splicing/physiology , RNA, Messenger/metabolism , Radioligand Assay , Receptors, G-Protein-Coupled/metabolism , Receptors, Neuropeptide/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Tissue Distribution , Transfection
16.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 24(3): 254-8, 2002 Jun.
Article in Chinese | MEDLINE | ID: mdl-12905629

ABSTRACT

OBJECTIVE: To identify and clone the gene encoding human M96 gene and study its expression spectrum in several blood cell lines. METHODS: According to the sequence of human EST which was highly homologous to the mouse M96 gene, primers used for library screening were synthesized, then the human adult testis and fetal brain cDNA library were screened. The gene was analyzed by making use of BLAST and CLUSTAL W, and its expression spectrum was studied by multiple-cell lines Northern blot analysis. The expression change of M961 in cell differentiation was observed by use of K562 cell line induced by hemin. RESULTS: Two cDNA clones encoding human M96 gene were isolated, identified and named as M961, and M962. They were found to be isoforms of each other. Northern, blot showed that M961 gene was expressed highly in CEM, Hel, Dami and K562 cell lines. However, during K562 cell line differentiation, process the expression of M961 elevated only slightly. CONCLUSIONS: M961 gene was expressed highly in pluripotent cell lines with erythrocytic and megakaryocytic potentials.


Subject(s)
Alternative Splicing , DNA, Complementary/genetics , DNA, Neoplasm/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA, Neoplasm/isolation & purification , Hemin/pharmacology , Humans , K562 Cells , Molecular Sequence Data , Protein Isoforms/genetics , Protein Isoforms/isolation & purification , Protein Splicing , Zinc Fingers/genetics
17.
Article in Chinese | WPRIM | ID: wpr-301879

ABSTRACT

<p><b>OBJECTIVE</b>To identify and clone the gene encoding human M96 gene and study its expression spectrum in several blood cell lines.</p><p><b>METHODS</b>According to the sequence of human EST which was highly homologous to the mouse M96 gene, primers used for library screening were synthesized, then the human adult testis and fetal brain cDNA library were screened. The gene was analyzed by making use of BLAST and CLUSTAL W, and its expression spectrum was studied by multiple-cell lines Northern blot analysis. The expression change of M961 in cell differentiation was observed by use of K562 cell line induced by hemin.</p><p><b>RESULTS</b>Two cDNA clones encoding human M96 gene were isolated, identified and named as M961, and M962. They were found to be isoforms of each other. Northern, blot showed that M961 gene was expressed highly in CEM, Hel, Dami and K562 cell lines. However, during K562 cell line differentiation, process the expression of M961 elevated only slightly.</p><p><b>CONCLUSIONS</b>M961 gene was expressed highly in pluripotent cell lines with erythrocytic and megakaryocytic potentials.</p>


Subject(s)
Humans , Alternative Splicing , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA, Complementary , Genetics , DNA, Neoplasm , Genetics , Hemin , Pharmacology , K562 Cells , Molecular Sequence Data , Protein Isoforms , Genetics , Protein Splicing , Zinc Fingers , Genetics
18.
J Biol Chem ; 274(26): 18359-63, 1999 Jun 25.
Article in English | MEDLINE | ID: mdl-10373440

ABSTRACT

Mini-inteins derived from Synechocystis sp. (Ssp DnaB intein) and Mycobacterium xenopi (Mxe GyrA intein) that have been modified to cleave peptide bonds at their C and N termini, respectively, were cloned in-frame to the N and C termini of a target protein. Peptide bond cleavage of the modified inteins generated an N-terminal cysteine and a C-terminal thioester on the same protein. These complementary reactive groups underwent intra- or intermolecular condensation to generate circular or polymeric protein species with a new peptide bond at the site of ligation. Three cyclic peptides, BBP, an organ specific localization peptide; RGD, an inhibitor of platelet aggregation; and CDR-H3/C2, which inhibits HIV-1 replication, were isolated using the two-intein system. BBP, RGD, and CDR-H3/C2 had masses of 977.1, 1119.9, and 2098.6 g/mol, respectively, as determined by matrix-assisted laser desorption-time of flight mass spectrometry, which agreed well with the values of 977.2, 1120.3, and 2098.3 g/mol, respectively, predicted for the cyclic species. This system was used to cyclize proteins as large as 395 amino acids. Furthermore, multimers of thioredoxin were formed upon concentration of the reactive species, indicating the potential to form novel biomaterials based on fibrous proteins.


Subject(s)
Bacterial Proteins/metabolism , DNA Helicases/metabolism , DNA Topoisomerases, Type II/metabolism , Peptides, Cyclic/metabolism , Polymers/metabolism , Protein Splicing , Amino Acid Sequence , Cyanobacteria , Cysteine/metabolism , DNA Gyrase , DnaB Helicases , Electrophoresis, Polyacrylamide Gel , Molecular Sequence Data , Mycobacterium xenopi
19.
J Biol Chem ; 274(7): 3923-6, 1999 Feb 12.
Article in English | MEDLINE | ID: mdl-9933578

ABSTRACT

The smallest known intein, found in the ribonucleoside diphosphate reductase gene of Methanobacterium thermoautotrophicum (Mth RIR1 intein), was found to splice poorly in Escherichia coli with the naturally occurring proline residue adjacent to the N-terminal cysteine of the intein. Splicing proficiency increased when this proline was replaced with an alanine residue. However, constructs that displayed efficient N- and C-terminal cleavage were created by replacing either the C-terminal asparagine or N-terminal cysteine of the intein, respectively, with an alanine. Furthermore, these constructs were used to specifically generate complementary reactive groups on protein sequences for use in ligation reactions. Reaction between an intein-generated C-terminal thioester on E. coli maltose-binding protein (43 kDa) and an intein-generated cysteine at the N terminus of either T4 DNA ligase (56 kDa) or thioredoxin (12 kDa) resulted in the ligation of the proteins through a native peptide bond. Thus the smallest of the known inteins is capable of splicing and its unique properties extend the utility of intein-mediated protein ligation to include the in vitro fusion of large, bacterially expressed proteins.


Subject(s)
Methanobacterium/enzymology , Protein Splicing , Ribonucleoside Diphosphate Reductase/genetics , Amino Acid Sequence , Cysteine/chemistry , Escherichia coli , Methanobacterium/genetics , Models, Chemical , Molecular Sequence Data , Proline/chemistry , Ribonucleoside Diphosphate Reductase/chemistry
20.
Hear Res ; 101(1-2): 55-61, 1996 Nov 01.
Article in English | MEDLINE | ID: mdl-8951432

ABSTRACT

Plasma membrane Ca-ATPase (PMCA) gene products were identified in the gerbil cochlea by reverse-transcription polymerase chain reaction (RT-PCR). Cochlear cDNA was amplified using PMCA isoform-specific primers from splice site C, the calmodulin binding domain. PCR products were cloned and sequenced. The putative housekeeping PMCA genes, 1b and 4b, as expected, were present in the gerbil cochlea and shared 98.6 and 100% amino acid homology with published rat sequences, at splice site C, respectively. PMCA2b, 3a and 3b splice variants also were detected in cochlear cDNAs and shared 95, 94.3 and 98% amino acid homology with their rat counterparts. PMCA isoforms 2 and 3 have been shown to occur in highly specialized tissues, such as muscle and brain, that require finely tuned regulation of intracellular free Ca2+ levels. The presence of several isoforms and splice variants of PMCA in the cochlea most probably reflects their differential expression among the several cell types that have been shown to contain immunoreactive PMCA. This suggests that the cochlea has developed complex mechanisms that finely tune intracellular Ca2+ levels in different highly specialized cell types.


Subject(s)
Calcium-Transporting ATPases/genetics , Cell Membrane/enzymology , Cochlea/enzymology , Amino Acid Sequence , Animals , Base Sequence , Calcium/metabolism , Calcium-Transporting ATPases/metabolism , Calmodulin/metabolism , Cloning, Molecular , DNA, Complementary/genetics , DNA, Complementary/metabolism , Exons , Female , Gene Expression Regulation, Enzymologic/genetics , Gerbillinae , Homeostasis , Ion Transport , Isoenzymes , Male , Molecular Sequence Data , Polymerase Chain Reaction , Protein Splicing , Rats , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL